Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

NCT00197184

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • GSK Investigational Site North Adelaide, South Australia, Australia
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Barcelona, Spain
View Trial Details
Completed

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bindlach, Bavaria, Germany
  • GSK Investigational Site Kirchheim, Bavaria, Germany
View Trial Details
Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

NCT01138098

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Banská Bystrica, Slovakia
  • GSK Investigational Site Dolný Kubín, Slovakia
  • GSK Investigational Site Dubnica nad Váhom, Slovakia
  • GSK Investigational Site Martin, Slovakia
View Trial Details
Completed

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

NCT00197236

Conditions
Digestive System Diseases, Enterovirus Infections, Hepatitis, +7 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site San Ramon, California, United States
  • GSK Investigational Site Wilmington, Delaware, United States
View all 22 locations
View Trial Details
Completed

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • GSK Investigational Site Birkenfeld, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details

Related conditions